{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:31:20Z","timestamp":1791228680880,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.2353\/ajpath.2006.051078","type":"journal-article","created":{"date-parts":[[2006,12,13]],"date-time":"2006-12-13T19:55:19Z","timestamp":1166039719000},"page":"2171-2180","source":"Crossref","is-referenced-by-count":91,"title":["Activation of Mammalian Target of Rapamycin Signaling Promotes Cell Cycle Progression and Protects Cells from Apoptosis in Mantle Cell Lymphoma"],"prefix":"10.1016","volume":"169","author":[{"given":"Evangelia","family":"Peponi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Drakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Leventaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Z.","family":"Rassidakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2006.051078_bib1","series-title":"World Health Organization Classification of Tumours","first-page":"168","article-title":"Mante cell lymphoma","author":"Swerdlow","year":"2001"},{"key":"10.2353\/ajpath.2006.051078_bib2","doi-asserted-by":"crossref","first-page":"9638","DOI":"10.1073\/pnas.88.21.9638","article-title":"PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma","volume":"88","author":"Rosenberg","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2006.051078_bib3","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1182\/blood.V76.10.2086.2086","article-title":"Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation","volume":"76","author":"Medeiros","year":"1990","journal-title":"Blood"},{"key":"10.2353\/ajpath.2006.051078_bib4","first-page":"5541s","article-title":"Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma","volume":"52","author":"Williams","year":"1992","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2006.051078_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1365-2141.2003.04761.x","article-title":"Molecular basis of mantle cell lymphoma","volume":"124","author":"Bertoni","year":"2004","journal-title":"Br J Haematol"},{"key":"10.2353\/ajpath.2006.051078_bib6","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/j.1460-2075.1994.tb06488.x","article-title":"Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene","volume":"13","author":"Bodrug","year":"1994","journal-title":"EMBO J"},{"key":"10.2353\/ajpath.2006.051078_bib7","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1002\/j.1460-2075.1994.tb06655.x","article-title":"Cyclin D1\/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice","volume":"13","author":"Lovec","year":"1994","journal-title":"EMBO J"},{"key":"10.2353\/ajpath.2006.051078_bib8","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.onc.1209147","article-title":"Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma","volume":"25","author":"Gladden","year":"2006","journal-title":"Oncogene"},{"key":"10.2353\/ajpath.2006.051078_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/01.cco.0000174039.69656.2b","article-title":"Biology and therapy of mantle cell lymphoma","volume":"17","author":"Williams","year":"2005","journal-title":"Curr Opin Oncol"},{"key":"10.2353\/ajpath.2006.051078_bib10","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev"},{"key":"10.2353\/ajpath.2006.051078_bib11","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/sj.onc.1207542","article-title":"Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression","volume":"23","author":"Fingar","year":"2004","journal-title":"Oncogene"},{"key":"10.2353\/ajpath.2006.051078_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","article-title":"mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery","volume":"110","author":"Kim","year":"2002","journal-title":"Cell"},{"key":"10.2353\/ajpath.2006.051078_bib13","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr Biol"},{"key":"10.2353\/ajpath.2006.051078_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.semcdb.2003.12.023","article-title":"PI3-kinase and TOR: pIKTORing cell growth","volume":"15","author":"Richardson","year":"2004","journal-title":"Semin Cell Dev Biol"},{"key":"10.2353\/ajpath.2006.051078_bib15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1128\/MCB.24.1.200-216.2004","article-title":"mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1\/eukaryotic translation initiation factor 4E","volume":"24","author":"Fingar","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.2353\/ajpath.2006.051078_bib16","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"key":"10.2353\/ajpath.2006.051078_bib17","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/35096067","article-title":"PKB\/AKT: functional insights from genetic models","volume":"2","author":"Scheid","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.2353\/ajpath.2006.051078_bib18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-kinase AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.2353\/ajpath.2006.051078_bib19","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1073\/pnas.0408864102","article-title":"Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic","volume":"102","author":"Kang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2006.051078_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.semcdb.2004.11.005","article-title":"mTOR, translational control and human disease","volume":"16","author":"Tee","year":"2005","journal-title":"Semin Cell Dev Biol"},{"key":"10.2353\/ajpath.2006.051078_bib21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature02369","article-title":"Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy","volume":"428","author":"Wendel","year":"2004","journal-title":"Nature"},{"key":"10.2353\/ajpath.2006.051078_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.gde.2004.11.002","article-title":"TSC1\u20132 tumour suppressor and regulation of mTOR signalling: linking cell growth and proliferation?","volume":"15","author":"Findlay","year":"2005","journal-title":"Curr Opin Genet Dev"},{"key":"10.2353\/ajpath.2006.051078_bib23","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.cellsig.2004.03.019","article-title":"The Rheb family of GTP-binding proteins","volume":"16","author":"Aspuria","year":"2004","journal-title":"Cell Signal"},{"key":"10.2353\/ajpath.2006.051078_bib24","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.2353\/ajpath.2006.051078_bib25","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1182\/blood-2005-03-0929","article-title":"Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells","volume":"106","author":"Avellino","year":"2005","journal-title":"Blood"},{"key":"10.2353\/ajpath.2006.051078_bib26","doi-asserted-by":"crossref","first-page":"15113","DOI":"10.1073\/pnas.2436348100","article-title":"Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling","volume":"100","author":"Brown","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2006.051078_bib27","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1182\/blood-2004-03-1153","article-title":"In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model","volume":"104","author":"Frost","year":"2004","journal-title":"Blood"},{"key":"10.2353\/ajpath.2006.051078_bib28","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1182\/blood-2003-05-1543","article-title":"Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone","volume":"103","author":"Str\u00f6mberg","year":"2004","journal-title":"Blood"},{"key":"10.2353\/ajpath.2006.051078_bib29","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1200\/JCO.2005.13.466","article-title":"Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma","volume":"23","author":"Witzig","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.2353\/ajpath.2006.051078_bib30","doi-asserted-by":"crossref","first-page":"424","DOI":"10.5858\/2003-127-0424-COMCLC","article-title":"Characterization of 4 mantle cell lymphoma cell lines","volume":"127","author":"Amin","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.2353\/ajpath.2006.051078_bib31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.leukres.2005.08.026","article-title":"Z-138 cell line was derived from a patient with blastoid variant mantle cell lymphoma","volume":"30","author":"Medeiros","year":"2006","journal-title":"Leuk Res"},{"key":"10.2353\/ajpath.2006.051078_bib32","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/S0021-9258(17)37680-9","article-title":"A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)","volume":"269","author":"Vlahos","year":"1994","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2006.051078_bib33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/path.1254","article-title":"Expression of Mcl-1 in mantle cell lymphoma is associated with high-grade morphology, a high proliferative state, and p53 overexpression","volume":"199","author":"Khoury","year":"2003","journal-title":"J Pathol"},{"key":"10.2353\/ajpath.2006.051078_bib34","doi-asserted-by":"crossref","first-page":"990","DOI":"10.5858\/2005-129-990-ASOTSP","article-title":"Activation status of the JAK\/STAT3 pathway in mantle cell lymphoma","volume":"129","author":"Yared","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"10.2353\/ajpath.2006.051078_bib35","series-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues","first-page":"230","article-title":"Anaplastic large cell lymphoma","author":"Delsol","year":"2001"},{"key":"10.2353\/ajpath.2006.051078_bib36","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1158\/0008-5472.CAN-05-3018","article-title":"Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma","volume":"66","author":"Vega","year":"2006","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2006.051078_bib37","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1002\/j.1460-2075.1996.tb00911.x","article-title":"Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002","volume":"15","author":"Brunn","year":"1996","journal-title":"EMBO J"},{"key":"10.2353\/ajpath.2006.051078_bib38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nm1042","article-title":"The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis","volume":"10","author":"Ruggero","year":"2004","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2006.051078_bib39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrc1015","article-title":"Does the ribosome translate cancer?","volume":"3","author":"Ruggero","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.2353\/ajpath.2006.051078_bib40","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1074\/jbc.M208821200","article-title":"Translation factor eIF4E rescues cells from Myc-dependent apoptosis by inhibiting cytochrome c release","volume":"278","author":"Li","year":"2003","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2006.051078_bib41","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1182\/blood-2002-06-1688","article-title":"Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression","volume":"101","author":"Woltman","year":"2003","journal-title":"Blood"},{"key":"10.2353\/ajpath.2006.051078_bib42","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1084\/jem.20031080","article-title":"c-FLIP mediates resistance of Hodgkin\/Reed-Sternberg cells to death receptor-induced apoptosis","volume":"199","author":"Mathas","year":"2004","journal-title":"J Exp Med"},{"key":"10.2353\/ajpath.2006.051078_bib43","doi-asserted-by":"crossref","first-page":"21176","DOI":"10.1074\/jbc.270.36.21176","article-title":"Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels","volume":"270","author":"Rosenwald","year":"1995","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2006.051078_bib44","doi-asserted-by":"crossref","first-page":"8204","DOI":"10.1073\/pnas.0502857102","article-title":"The coordinate regulation of the p53 and mTOR pathways in cells","volume":"102","author":"Feng","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2006.051078_bib45","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2004-06-2125","article-title":"Inhibition of Akt increases p27Kip1 levels and induces cell cycle arrest in anaplastic large cell lymphoma","volume":"105","author":"Rassidakis","year":"2005","journal-title":"Blood"},{"key":"10.2353\/ajpath.2006.051078_bib46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tibs.2004.11.003","article-title":"Restraining PI3K: mTOR signalling goes back to the membrane","volume":"30","author":"Harrington","year":"2005","journal-title":"Trends Biochem Sci"},{"key":"10.2353\/ajpath.2006.051078_bib47","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1158\/0008-5472.CAN-05-0917","article-title":"Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition","volume":"65","author":"Sun","year":"2005","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2006.051078_bib48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0002-9440(10)65118-8","article-title":"Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas","volume":"155","author":"Wang","year":"1999","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2006.051078_bib49","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2005.05630.x","article-title":"Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways","volume":"130","author":"Rizzatti","year":"2005","journal-title":"Br J Haematol"},{"key":"10.2353\/ajpath.2006.051078_bib50","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2004-10-3999","article-title":"Proteomic analysis of mantle-cell lymphoma by protein microarray","volume":"105","author":"Ghobrial","year":"2005","journal-title":"Blood"},{"key":"10.2353\/ajpath.2006.051078_bib51","doi-asserted-by":"crossref","first-page":"14340","DOI":"10.1073\/pnas.011511898","article-title":"Cytoplasmic-nuclear shuttling of FKBP12-rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation","volume":"97","author":"Kim","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2006.051078_bib52","doi-asserted-by":"crossref","first-page":"28127","DOI":"10.1074\/jbc.M202625200","article-title":"Predominant nuclear localization of mammalian target of rapamycin in normal and malignant cells in culture","volume":"277","author":"Zhang","year":"2002","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2006.051078_bib53","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/path.1725","article-title":"Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR","volume":"205","author":"Dutton","year":"2005","journal-title":"J Pathol"},{"key":"10.2353\/ajpath.2006.051078_bib54","doi-asserted-by":"crossref","first-page":"25485","DOI":"10.1074\/jbc.M501707200","article-title":"Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase","volume":"280","author":"Chiang","year":"2005","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2006.051078_bib55","doi-asserted-by":"crossref","first-page":"26089","DOI":"10.1074\/jbc.M504045200","article-title":"Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase","volume":"280","author":"Holz","year":"2005","journal-title":"J Biol Chem"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010626764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010626764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:56:57Z","timestamp":1628211417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010626764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0002944010626764"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2006.051078","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}